- Home
- CFR vs PODD Comparison
CFR vs PODD Comparison
Compare CFR & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CFR | PODD |
|---|---|---|
| Founded | 1868 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.3B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CFR | PODD |
|---|---|---|
| Price | $162.88 | $144.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 21 |
| Target Price | $142.31 | ★ $341.48 |
| AVG Volume (30 Days) | 547.6K | ★ 1.7M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ 11.84 | N/A |
| EPS | ★ 5.35 | 2.67 |
| Revenue | $2,235,244,000.00 | ★ $2,708,100,000.00 |
| Revenue This Year | $9.72 | $24.55 |
| Revenue Next Year | $4.70 | $19.18 |
| P/E Ratio | ★ $30.73 | $54.46 |
| Revenue Growth | 8.31 | ★ 30.73 |
| 52 Week Low | $119.00 | $126.40 |
| 52 Week High | $170.80 | $354.88 |
Technical Indicators
Market Signals| Indicator | CFR | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 43.52 |
| Support Level | $162.32 | $139.23 |
| Resistance Level | $163.81 | $170.20 |
| Average True Range (ATR) | 2.84 | 5.61 |
| MACD | -0.98 | 0.06 |
| Stochastic Oscillator | 9.67 | 57.60 |
Price Performance
Historical ComparisonAbout CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.